ArticleScience advances2022

Spatial interplay patterns of cancer nuclei and tumor-infiltrating lymphocytes (TILs) predict clinical benefit for immune checkpoint inhibitors.

Xiangxue Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.